✦ LIBER ✦

Phase II study with gemcitabine and paclitaxel administered once every two weeks in chemonaive advanced stage non-small cell lung cancer (NSCLC) patients

✍ Scribed by Fontaine, C; Joos, G; De Grève, J; De Mey, J; Van Klaveren, R; Neyns, B; Van de Velde, V; Stappaerts, I; Pinson, P; Grauwels, D; Van Hulle, J; Schallier, D

Book ID: 118569589
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 106 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80044-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study with Taxol® (paclitaxel)

Phase II study with Taxol® (paclitaxel) and Gemzar® (gemcitabine) in metastatic non-small cell lung cancer (NSCLC)

✍ Douillard, J.Y; Lerouge, D; Monnier, A; Sun, X.S; Haller, M.A; Assouline, D; Gra 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 218 KB

A phase II study of modulated-capecitabi

A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)

✍ Bertino, Erin M.; Bekaii-Saab, Tanios; Fernandez, Soledad; Diasio, Robert B.; Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Mature Results of a Phase II Trial of Ge

Mature Results of a Phase II Trial of Gemcitabine/Paclitaxel Given Every 2 Weeks in Patients with Advanced Non–Small-Cell Lung Cancer

✍ Antoinette J. Wozniak; Kimberly Belzer; Lance K. Heilbrun; Omer Kucuk; Shirish G 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 125 KB

Gemcitabine, ifosfamide and paclitaxel i

Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study

✍ F. V. Piantedosi; F. Caputo; G. Mazzarella; M. Gilli; A. Pontillo; D. D’Agostino 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 206 KB

A multicenter, phase II study of combina

A multicenter, phase II study of combination paclitaxel/gemcitabine in previously untreated stage IV non-small cell lung (NSCLC) cancer patients

✍ Edelman, G; Melville, S; Meyer, W; Napier, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

P-546 Phase I/II trial of patupilone onc

P-546 Phase I/II trial of patupilone once every 3 weeks in patients with non-small cell lung cancer (NSCLC)

✍ Østerlind, K.; Sánchez, J.; Zatloukal, P.; Hamm, J.; Belani, C.; Kim, E.; Felip, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 121 KB